retatrutide weight loss efficacy safety trial results First phase 3 data, a Triumph of Science! Weight-loss medicine continues to evolve. – 30 Days of Retatrutide —

They conducted the Study of Tirzepatide Compared with Dulaglutide on Major Cardiovascular Events in Participants with Type 2 Diabetes (SURPASS-CVOT) to settle a couple of questions, explains Nicholls: Given that there is a lot of interest in developing new incretin therapies, can we achieve better outcomes (metabolic or clinical) with combination therapy, and can we develop agents that are better tolerated

da Silva, Implications of GLP-1 agonist use on airway management, Am

1986 Aug;63(2):4127

Grapefruit has a natural ability to block an enzyme called CYP3A4, which is important to the absorption of medications